GC Biopharma signs ₩59.2bn influenza vaccine supply contract
GC Biopharma · KOSPI · 006280 · Nov 2, 2026
· Supply contracts
GC Biopharma filed a supply contract for influenza vaccines with VaxThera Zona Franca S.A.S., with a contract amount of ₩59.2bn. The filing reports the contract as 3.0% of revenue, and the contract period runs from Oct 30, 2026 to Oct 30, 2036. The filing date is Nov 2, 2026.
Key facts
| Contract name | Influenza vaccine supply contract |
| Counterparty | VaxThera Zona Franca S.A.S. |
| Contract amount | ₩59.2bn |
| % of revenue (as reported) | 3.0% |
| Period start | Oct 30, 2026 |
| Period end | Oct 30, 2036 |
Comparison
| Amount as % of FY2025 revenue (calculated) | 3.0% |
|---|
| Revenue 2025 | ₩2.0tn |
| Revenue 2024 | ₩1.7tn |
| Revenue 2023 | ₩1.6tn |
Key metrics
Supply contracts
| Supply contracts, last 12 months | ₩59.2bn As of Nov 2, 2026 Source 1 |
| Supply contracts vs prior-year revenue | 3.0% As of Nov 2, 2026 Source 1 |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded As of Nov 19, 2026 |
Related filings
Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)